In this note McKinsey & Company offer its latest insights on the COVID-19 pandemic, starting with a survey of the current epidemiology and the five dynamics leaders need to watch: the efficacy of the surge in critical care, the expansion of testing and other traditional approaches, the development of antibody testing, the unknown nature of immunity, and a wave of innovation that might produce treatments and vaccines.
They then highlight four other recently published articles, each designed to help senior executives think through the challenges of restarting economies.
